Navigation Links
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
Date:10/3/2008

er patients."

"The collaboration and license agreement with Lilly marks an important milestone in the growth and development of our company," said Daniel Flynn, President & CEO of Deciphera. "Lilly's strength in drug discovery and development, and in particular their commitment to cancer drug research, provides Deciphera with the opportunity to advance our B-Raf kinase 'switch pocket' inhibitors into the clinic and ultimately to patients in need of these therapies. We are very pleased to have Lilly as our partner in this endeavor."

About B-Raf Inhibitors

BRAF kinase is one of the most frequently mutated members of the kinase family across all cancers, and is particularly common in malignant melanomas, colon, and thyroid cancers. The V600E mutant form of BRAF kinase in particular has been associated with increased tumor aggressiveness and decreased survival rates in many types of cancers. Deciphera is pursuing two distinct strategies centered on BRAF inhibition. The first strategy seeks potent and highly selective BRAF inhibitors. The second strategy pursues BRAF inhibitors which also inhibit other kinases of interest.

About Deciphera

Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce "best-in-class" small molecule switch inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace through the use of its proprietary drug discovery technology platform, Phylomechanics. Deciphera's kinase inhibitors target the mechanisms that render kinases oncogenic, retain potency against gatekeeper mutations, and afford selectivity profiles not easily attained by other approaches. For more information, visit the Company's website at http://www.deciphera.com.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
3. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
4. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
5. Lilly and TransPharma Medical Announce Licensing and Development Agreement
6. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
7. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
8. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
9. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
10. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
11. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  Now that Intuitive Surgical, Inc.® has announced that ... hospitals with robotic surgery programs need to think about ... where they stand with robotic surgery. Are they performing ... adopted best practices for safety? Should they plan to ... ECRI Institute, which has nearly 50 years, experience ...
(Date:8/27/2015)... , Aug. 27, 2015   ... Pharmacy Provider (IOPP™) is expanding its population ... a medication-focused transition of care program for ... "RxCare Management," provides hospitals with technology systems ... performance measures that have been mandated by ...
(Date:8/27/2015)... Ohio , Aug. 27, 2015  A mere ... to Booz Allen Hamilton . A new ... product development inefficiencies are impeding and disrupting manufacturers, success. ... Cut Waste and Improve Value In Product Development Processes ... of inaccessible data and how it affects the product ...
Breaking Medicine Technology:ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2
... Va., Oct. 30 CEL-SCI Corporation,(Amex: CVM ) ... at the Rodman & Renshaw 9th Annual Healthcare Conference ... 5-7, 2007. The presentation,will be focused on its Phase ... product seeking to become a new first line standard ...
... the Potential ... INDIANAPOLIS and MUMBAI, India, Oct. 30 Eli,Lilly and Company ... into an,agreement with Glenmark Pharmaceuticals S.A. (GPSA) a wholly owned,subsidiary ... agreement, Lilly will acquire the rights to a portfolio of ...
Cached Medicine Technology:CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 3Lilly and Glenmark Pharmaceuticals Announce License Agreement 4Lilly and Glenmark Pharmaceuticals Announce License Agreement 5
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL ... with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 ... 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... specialist, Dr. James Strawbridge, gives a new approach on solutions in his new ... with the employer and employees getting together for meaningful group meetings. "This would ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... ... , ... The Quatela Center for Plastic Surgery is excited to bring patients ... approved by the Food and Drug Administration to eliminate submental fat, also known as ... are among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     ...
(Date:8/28/2015)... ... August 28, 2015 , ... SharkNinja, an innovative leader ... and Emmy-nominated actress, Sofia Vergara, and unveil the Ninja® brand’s new coffee ... which delivers a variety of sizes and styles while achieving the perfect brew ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... TCS Founder Pock Presents Gift to CMSA Foundation President ... AUBURN, Calif., July 16 TCS Healthcare Technologies (TCS), ... an unrestricted grant of $5,000 to the Case Management Society of America ... , , Rob Pock, TCS ...
... HOFFMAN ESTATES, Ill., July 16 St. Alexius Medical Center, Hoffman Estates, ... annual America,s Best Hospitals list published by U.S. News ... ranked among the top 50 hospitals in the nation for the treatment ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090716/CG47487 ) , , ...
... Calif., July 16 MO BIO Laboratories, Inc., the ... of an innovative new product, PowerFood(TM) Microbial DNA Isolation Kit, designed ... , The PowerFood Microbial DNA Isolation Kit ... that allows for isolation of DNA from a variety of gram ...
... , , PALO ALTO, Calif., July ... been elected chairman of the company,s Board of Directors. , ... biotechnology industry, and as the former chairman of Connetics Corporation and ... and success to TOPICA, as well as an exceptional knowledge of ...
... , , CHICAGO, July 16 ... provides health care services for those needing sub-acute medical and ... its board of directors has named Dale Zaletel as the ... Zaletel, who previously held the position of Chief Operating Officer ...
... , , Gamers Engage ... NEW YORK, July 16 /PRNewswire-USNewswire/ -- The MS ... sclerosis (MS) to exercise their brain power. The Collaborative, an alliance ... announced the launch of MyBrainGames, a free suite of online cognitive games ...
Cached Medicine News:Health News:TCS Healthcare Technologies Provides $5,000 Seed Money to Help Fund New CMSA Foundation 2Health News:TCS Healthcare Technologies Provides $5,000 Seed Money to Help Fund New CMSA Foundation 3Health News:St. Alexius Medical Center Named to America's Best Hospitals Rankings 2Health News:MO BIO Laboratories, Inc. Launches PowerFood(TM) Microbial DNA Isolation Kit 2Health News:TOPICA Elects G. Kirk Raab as Chairman of the Board 2Health News:Lexington Health Care Names New Chief Executive Officer 2Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 2Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 3Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 4
... Are Turned 90 Degrees To Allow ... While Incising Tissue. ,Special Mirror-Polished Double Footplate ... Blade Extension Settings Of 0.5mm, 0.55mm, ... Extension.,1mm Wide Snub Nose Diamond Blade ...
... Unique In-Line Footplates Are Turned ... Of The Diamond Blade While Incising ... Precise Blade Depth Penetration.,Pre-Set Blade Extension ... Full Retraction And Full Extension.,1mm Wide ...
... 23g Tube Allows Use Through A ... More Comfortable Approach To The Incision.,Cystotome ... Capsule To Initiate And Complete A ... Weight For Improved Ergonomic Feel. Ideal ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Medicine Products: